By IQVIAs latest tracking, China accounts for a large share of global generic semaglutide manufacturing: there are currently 74 Chinese developers, including CDMOs and full developers, with many using synthetic approaches, alongside growing manufacturing activity in India and other geographies
This combined receptor activation results in a synergistic effect on body weight reduction through increased energy expenditure, decreased food intake, delayed gastric emptying, and stimulation of lipolysis
The upside is feeling fuller, longer
Pollytia Panagiotou, MD First Ill say that for diabetes management, now these medications have totally replaced the other prerequisites, such as Metformin and other class drugs that we use for diabetes, and we jump straight to that, and we see better control right from the get go with diabetes
Weve also seen a backlash against sunscreen among some young people, again promoted on TikTok
pricing pressure, Novo is girding for competition from Eli Lilly on the oral weight-loss front as the Indianapolis-based drugmaker expects to launch its own pill in the second quarter